Prognostic role of lipids, apolipoproteins in patients with resectable hepatocellular carcinoma

Xiaochun Ni,Yong Yi,Yipeng Fu,Xiaoyan Cai,Gao Liu,Jinlong Huang,Wei Gan,Jie Xu,Shuangjian Qiu

DOI: https://doi.org/10.21203/rs.2.23597/v1

2020-01-01

Abstract:Abstract Background: To further clarify the association between abnormal levels of serum lipid components as the main features of dyslipidaemia and hepatocellular cancinima, which remains unclear.Methods: We examined the serum level of lipids and apolipoproteins pattern in 471 patients undergoing curative resection for HCC, 193 patients with chronic liver disease, and 104 patients with benign liver diseases. We performed uni- and multivariate analyses to evaluate the predictive roles of lipids and apolipoproteins for recurrence and survival of HCC in a training cohort of 242 patients and then validated in a cohort of 229 patients.Results: The majority circuling lipid and apolipoprotein levels such as ApoA1, HDL, LDL in chronic liver disease and HCC were slight to significantly decreased as compared with those in benign lesion. But no significant differential expression patterns of lipids and apolipoproteins were observed between chronic liver hepatitis and HCC. Multivariable analysis identified ApoA1 as a key parameter related to recurrence and survival in both training and validation cohorts. Moreover, we further demonstrated that low ApoA1 was an independent prognostic factor of poor early recurrence in two cohorts.Conclusions: Although the alterations of circulating lipids and apolipoproteins were observed in HCC, none of lipids and apolipoproteins could serve as a diagnostic marker. Serum ApoA1 merits consideration as a novel prognostic marker for patients with HCC undergoing surgery, since it predicts early recurrence and survival, especially for early stage patients and may improve the prognostic stratification of patients for clinical management and promote HCC clinic outcomes.